Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain

Cellular and Molecular Immunology

Volumn 11, Issue 2, 2014, Pages 141-149

  Siu, Kam Leung ^a   Chan, Chi Ping ^a   Kok, Kin Hang ^a   Chiu Yat Woo, Patrick ^b   Jin, Dong Yan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Human coronavirus HKU1; Innate antiviral response; SARS coronavirus; TRAF3; Type I interferons

Indexed keywords

I KAPPA B KINASE EPSILON; INTERFERON; MEMBRANE PROTEIN; PROTEIN TBK1; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG; VIRUS M PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; GOLGI COMPLEX; HELA CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; SARS CORONAVIRUS; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS STRAIN;

CORONAVIRUS; GOLGI APPARATUS; HEK293 CELLS; HELA CELLS; HUMANS; I-KAPPA B KINASE; IMMUNE EVASION; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INTERFERON TYPE I; MEMBRANE PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SEVERE ACUTE RESPIRATORY SYNDROME; TNF RECEPTOR-ASSOCIATED FACTOR 3; VIRAL MATRIX PROTEINS;

EID: 84895546659     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.61     Document Type: Article

References (37)

1. Randall RE, Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89: 1-47
2. Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia, J Virol 2005; 79: 884-895
3. Peiris JS, Lai ST, Poon LL, Guan Y, YamLY, LimWet al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361: 1319-1325
4. Cheng VC, Lau SK, Woo PC, Yuen, KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007; 20: 660-694
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814- 1820
6. Lau SK, Woo PC, Yip CC, Tse H, Tsoi HW, Cheng VC et al. Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 2006; 44: 2063-2071
7. Jevsnik M, Ursic T, Zigon N, Lusa L, Krivec U, Petrovec M. Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease. BMC Infect Dis 2012; 12: 365
8. Woo PC, Lau SK, Yip CC, Huang Y, Yuen KY. More and more coronaviruses: Human coronavirus HKU1. Viruses 2009; 1: 57-71
9. Totura AL, Baric RS. SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2012; 2: 264-275
10. Moresco EM, LaVine D, Beutler B. Toll-like receptors. Curr Biol 2011; 21: R488-R493
11. Goubau D, Deddouche S, Reis E, Sousa C. Cytosolic sensing of viruses. Immunity 2013; 38: 855-869
12. Oostra M, de Haan CA, de Groot RJ, Rottier PJ. Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J Virol 2006; 80: 2326-2336
13. Siu YL, Teoh KT, Lo J, Chan CM, Kien F, EscriouN et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol 2008; 82: 11318-11330
14. Siu KL, Kok KH, Ng MH, Poon VK, Yuen KY, Zheng BJ et al. Severe acute respiratory syndrome coronavirus M protein inhibits type I i n t e r f eron production by impeding the formation of TRAF3?TANK?TBK1/IKKe complex. J Biol Chem 2009; 284: 16202-16209
15. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737
16. Guo B, Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 2007; 282: 11817- 11826
17. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002; 17: 251-263
18. Kok KH, Lui PY, Ng MH, Siu KL, Au SW, Jin DY. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011; 9: 299- 309
19. Siu KL, Chan CP, Chan C, Zheng BJ, Jin DY. Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of human FGL2 gene. J Gen Virol 2009; 90: 2107- 2113
20. Ching YP, Chan SF, Jeang KT, Jin DY. Retroviral oncoprotein Tax targets coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication. Nat Cell Biol 2006; 8: 717-724
21. Chin KT, Chun AC, Ching YP, Jeang KT, Jin DY. Human T-cell leukemia virus oncoprotein Tax represses nuclear receptordependent transcription by targeting coactivator TAX1BP1. Cancer Res 2007; 67: 1072-1081
22. Chan CP, Kok KH, Tang HM, Wong CM, Jin DY. Internal ribosome entry site-mediated translational regulation of ATF4 splice variant in mammalian unfolded protein response. Biochim Biophys Acta 2013; 1833: 2165-2175
23. Tang HM, Gao WW, Chan CP, Siu YT, Wong CM, Kok KH et al. LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology 2013; 10: 40
24. Schafer SL, Lin R, Moore PA, Hiscott J, Pitha PM. Regulation of type I interferon gene expression by interferon regulatory factor-3. J Biol Chem 1998; 273: 2714-2720
25. Zhang L, Pagano JS. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol 2000; 74: 1061-1068
26. Vigerust DJ, Shepherd VL. Virus glycosylation: Role in virulence and immune interactions. Trends Microbiol 2007; 15: 211-218
27. Voss D, Pfefferle S, Drosten C, Stevermann L, Traggiai E, Lanzavecchia A et al. Studies on membrane topology, Nglycosylation and functionality of SARS-CoV membrane protein. Virol J 2009; 6: 79
28. Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, Slusarewicz P et al. Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol 1995; 131: 1715-1726
29. Rajagopalan S, Xu Y, Brenner MB. Retention of unassembled components of integral membrane proteins by calnexin. Science 1994; 263: 387-390
30. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T et al. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 2013; 87: 12489-12495
31. Siu KL, Yeung ML, Kok KH, Yuen KS, Kew C, Lui PY et al. Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in innate antiviral response. J Virol 2014; 88: In press.
32. Siu KL, Chan CP, Woo PC, Jin DY. Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1. Cell Biosci 2014; 4: 3
33. Chan JF, Lau SK, Woo PC. The emerging novel Middle East respiratory syndrome coronavirus: The "knowns" and "unknowns". J Formos Med Assoc 2013; 112: 372-381
34. Pyrc K, Sims AC, Dijkman R, Jebbink M, Long C, Deming D et al. Culturing the unculturable: Human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. J Virol 2010; 84: 11255-11263
35. Dominguez SR, Travanty EA, Qian Z, Mason RJ. Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: Cytopathic effects and innate immune response. PLoS ONE 2013; 8: E70129
36. Dijkman R, Jebbink MF, Koekkoek SM, Deijs M, Jo'nsdó ttir HR, Molenkamp R et al. Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol 2013; 87: 6081-6090
37. Ng MHJ, Ho TH, Kok KH, Siu KL, Li J, Jin DY. MIP-T3 is a negative regulator of innate type I interferon response. J Immunol 2011; 187: 6473-6482